A multicenter, randomized, controlled, phase iii trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2014
This article has no abstract
Epistemonikos ID: fd201bc50ad278f2f23e5bc61d33ed0ba17c3d14
First added on: Apr 30, 2026